Scotts Miracle-Gro stock snapshot after recent performance
Scotts Miracle-Gro (SMG) has drawn fresh attention after recent share price moves, with the stock last closing at $68.11. Investors are reassessing the lawn and garden supplier using its latest return and earnings figures.
See our latest analysis for Scotts Miracle-Gro.
Recent trading in Scotts Miracle-Gro reflects building momentum, with a 7-day share price return of 7.28% and a 30-day share price return of 15.44%, set against a mixed picture that includes a 6.08% 1-year total shareholder return and a 55.66% decline in total shareholder return over five years.
If this kind of rebound catches your eye, it can be useful to see what else is moving and compare ideas using our screener of 20 top founder-led companies
With Scotts Miracle-Gro now trading at $68.11 and showing mixed long term returns, the key question is whether the current valuation still leaves a margin of safety or if the market is already pricing in future growth.
Most Popular Narrative: 57% Overvalued
According to the most followed narrative on Scotts Miracle-Gro, the fair value estimate sits at $43.49, well below the recent $68.11 share price, which frames the current rally in a very different light.
SMG’s current valuation reflects lingering skepticism: concerns over cannabis demand, consumer spending softness, and execution risk. But it may also underappreciate the company’s positioning within professional cultivation.
Curious what turns that skepticism into a higher fair value for Scotts Miracle-Gro? The narrative leans heavily on earnings quality, margin rebuild, and a future profit multiple that is usually reserved for steadier compounders. The key financial hinges behind that $43.49 figure are all laid out in the full story.
Result: Fair Value of $43.49 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Scotts Miracle-Gro still faces risks, including pressure on cannabis cultivation demand and potential strain on margins if cost controls or pricing do not hold up.
Find out about the key risks to this Scotts Miracle-Gro narrative.
Another view on Scotts Miracle-Gro valuation
The user narrative pegs Scotts Miracle-Gro as 57% overvalued at $68.11 versus a $43.49 fair value, but the SWS DCF model points in the opposite direction, with a fair value of $78.78 and the stock trading 13.5% below that level. When the signals conflict, the question becomes which lens to trust more.
Look into how the SWS DCF model arrives at its fair value.
Next Steps
The mixed sentiment around Scotts Miracle-Gro, with both risks and rewards in play, makes now a good time to review the data directly and stress test your own thesis using the full breakdown of 4 key rewards and 1 important warning sign
Looking for more investment ideas beyond Scotts Miracle-Gro?
If Scotts Miracle-Gro has you thinking more broadly about your portfolio, do not stop here. New opportunities can pass quickly when you are not looking in the right places.
- Spot potential turnaround stories early by scanning 22 elite penny stocks with strong financials that pair lower share prices with stronger financial profiles than many investors expect.
- Build a watchlist of quality at a discount by checking the 43 high quality undervalued stocks that combine solid fundamentals with pricing that still looks reasonable.
- Steady your portfolio with businesses that aim for resilience first by reviewing our 74 resilient stocks with low risk scores before the crowd pays closer attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com